Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RGEN - Repligen Corp.


IEX Last Trade
150.77
0.020   0.013%

Share volume: 3,728,546
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$150.75
0.02
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
19%
Profitability 9%
Dept financing 33%
Liquidity 75%
Performance 12%
Company vs Stock growth
vs
Performance
5 Days
2.81%
1 Month
-6.02%
3 Months
1.86%
6 Months
-22.97%
1 Year
-12.53%
2 Year
-31.30%
Key data
Stock price
$150.77
P/E Ratio 
-4,446.64
DAY RANGE
N/A - N/A
EPS 
-$0.03
52 WEEK RANGE
$110.45 - $211.13
52 WEEK CHANGE
-$0.14
MARKET CAP 
8.453 B
YIELD 
N/A
SHARES OUTSTANDING 
56.006 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/29/2024
BETA 
1.55
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$933,242
AVERAGE 30 VOLUME 
$871,589
Company detail
CEO: Anthony Hunt
Region: US
Website: https://www.repligen.com/
Employees: 1,007
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.

Recent news